RNAZ: TransCode Therapeutics, Inc. Stock

by  •  • Comments Off on RNAZ: TransCode Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 8.32
Enterprise Value ($M) 2.51
Book Value ($M) -2.02
Book Value / Share -0.09
Price / Book -4.12
NCAV ($M) -2.22
NCAV / Share -0.10
Price / NCAV -3.75

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -2.30
Return on Equity (ROE) -3.65

Liquidity (mrq)
Quick Ratio 2.56
Current Ratio 2.56

Balance Sheet (mrq) ($M)
Current Assets 7.09
Assets 7.29
Liabilities 9.31
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -15.66
Net Income -16.75

Cash Flow Statement (mra) ($M)
Cash From Operations -13.34
Cash from Investing -0.02
Cash from Financing 16.40

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-20 13D Thomas Joseph Tracy 5.00
02-14 13G Anson Funds Management LP 9.90
01-03 13G Sabby Management, Llc 9.90
11-06 13G/A 3i, LP 0.00 -100.00
06-21 13D Fitzgerald Thomas A 5.50

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 1,669,046 5,145,799 32.44
2025-04-16 703,353 2,273,276 30.94
2025-04-15 271,113 755,425 35.89
2025-04-14 510,995 1,485,880 34.39

(click for more detail)

Similar Companies
RGC – Regencell Bioscience Holdings Limited RGLS – Regulus Therapeutics Inc.
RMTI – Rockwell Medical, Inc. RNTX – Rein Therapeutics Inc.
RNXT – RenovoRx, Inc.


Financial data and stock pages provided by
Fintel.io